Pierce Kristen has filed 3 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 1612099 shares of CERO THERAPEUTICS HOLDINGS, INC. ($CERO) on January 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Pierce Kristen | Chief Development Officer | A | Stock Option (Right to Buy) | 1612099 | $0.00 | 1,612,099.0000 | 1,264,884 | 9999.99% | 100.00% |
| May 30, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Pierce Kristen | Chief Development Officer | A | Stock Option (Right to Buy) | 154841 | $0.00 | 154,841.0000 | 3,427,616 | 9999.99% | 4.52% |
| Oct. 1, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Pierce Kristen | Chief Development Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 24,838 | 9999.99% | 100.00% |